Blinatumomab for MRD-Negative Acute Lymphoblastic Leukemia in Adults
Mark R. Litzow(Dana-Farber Cancer Institute), Martin S. Tallman(Memorial Sloan Kettering Cancer Center), Ryan J. Mattison(Dana-Farber Cancer Institute), Rupali Bhave(Atrium Health Wake Forest Baptist), Brent L. Wood(University of Southern California), Selina M. Luger(University of Pennsylvania), Julie Bergeron(University of Iowa), Shejal Patel(Dana-Farber Cancer Institute), Elad Sharon(National Cancer Institute), Deepa Jeyakumar(Dana-Farber Cancer Institute), Gang Wu(St. Jude Children's Research Hospital), Tara L. Lin(Dana-Farber Cancer Institute), Pankit Vachhani(University of Alabama at Birmingham), Hillard M. Lazarus(University Hospitals of Cleveland), Janis Racevskis(Montefiore Medical Center), Bhavana Bhatnagar(The Ohio State University), Wen-Chao Zhang(Dana-Farber Cancer Institute), Keith W. Pratz(University of Pennsylvania), Kathryn G. Roberts(St. Jude Children's Research Hospital), Charles G. Mullighan(St. Jude Children's Research Hospital), Harry P. Erba(Michigan Center for Translational Pathology), Richard F. Little(Dana-Farber Cancer Institute), Yaqi Zhao(St. Jude Children's Research Hospital), Cheryl L. Willman(Mayo Clinic), Michelle A. Elliott(Mayo Clinic), Shira Dinner(Dana-Farber Cancer Institute), Ti‐Cheng Chang(St. Jude Children's Research Hospital), Daniel A. Arber(University of Chicago), Richard M. Stone(Dana-Farber Cancer Institute), Ehab Atallah(Medical College of Wisconsin), Elisabeth Paietta(Montefiore Medical Center), Dimitrios Tzachanis(Dana-Farber Cancer Institute), Daniel J. DeAngelo(Dana-Farber Cancer Institute), Anjali S. Advani(Cleveland Clinic), Michaela Liedtke(Cancer Institute (WIA)), Noelle V. Frey(Hospital of the University of Pennsylvania), Geoffrey L. Uy(Memorial Sloan Kettering Cancer Center), Steven D. Gore(Yale Cancer Center), Jacob M. Rowe(City Of Hope National Medical Center), Zhuoxin Sun(Dana-Farber Cancer Institute), Yanming Zhang(Memorial Sloan Kettering Cancer Center), Matthew J. Wieduwilt(Atrium Health Wake Forest Baptist)
Cited by 213
Related Papers
The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia
|Blood|2016|10.2k
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k